CLGN CollPlant Biotechnologies | $4.48
+5.4% | 11/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 11/29/2024 |
SBEV Splash Beverage Group | $0.20
| 11/29/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.00 -> $0.50 | N/A | View details for HC Wainwright rating of Splash Beverage Group (NYSEAMERICAN:SBEV) on 11/29/2024 |
ALEC Alector | $2.59
+1.6% | 11/29/2024 | Target Lowered by | HC Wainwright | - | Buy | $35.00 -> $7.00 | N/A | View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 11/29/2024 |
AGEN Agenus | $3.42
-2.0% | 11/29/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 11/29/2024 |
OTLK Outlook Therapeutics | $2.05
+20.6% | 11/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Outlook Therapeutics (NASDAQ:OTLK) on 11/29/2024 |
ICCM IceCure Medical | $0.83
| 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 11/27/2024 |
|
ESPR Esperion Therapeutics | $2.80
+10.2% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 11/27/2024 |
FEMY Femasys | $1.12
+7.7% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 11/27/2024 |
MDWD MediWound | $17.47
+0.1% | 11/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $28.00 -> $25.00 | N/A | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 11/27/2024 |
SANA Sana Biotechnology | $2.78
+9.0% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 11/27/2024 |
CGTX Cognition Therapeutics | $0.40
| 11/27/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 11/27/2024 |
AVXL Anavex Life Sciences | $9.46
+4.8% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 11/27/2024 |
NNE Nano Nuclear Energy | $27.61
+3.1% | 11/27/2024 | Reiterated by | HC Wainwright | Analyst S. Joshi | Buy -> Buy | $50.00 -> $50.00 | N/A | View details for HC Wainwright rating of Nano Nuclear Energy (NASDAQ:NNE) on 11/27/2024 |
IREN Iris Energy | $13.51
+9.0% | 11/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $13.00 -> $16.00 | N/A | View details for HC Wainwright rating of Iris Energy (NASDAQ:IREN) on 11/27/2024 |
ELBM Electra Battery Materials | $0.50
+6.4% | 11/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.40 -> $1.30 | N/A | View details for HC Wainwright rating of Electra Battery Materials (NASDAQ:ELBM) on 11/27/2024 |
VKTX Viking Therapeutics | $52.94
-2.9% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $102.00 -> $102.00 | N/A | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 11/26/2024 |
PSTX Poseida Therapeutics | $9.31
-0.2% | 11/26/2024 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Neutral | $20.00 -> $9.00 | N/A | View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 11/26/2024 |
BHVN Biohaven | $46.01
-0.8% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 -> $59.00 | N/A | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 11/26/2024 |
SRRK Scholar Rock | $39.90
+4.6% | 11/26/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $40.00 -> $50.00 | N/A | View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 11/26/2024 |
INAB IN8bio | $0.30
+2.9% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | N/A | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 11/26/2024 |
ETON Eton Pharmaceuticals | $13.53
+6.2% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $15.00 | N/A | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 11/26/2024 |
RDW Redwire | $13.96
+3.5% | 11/26/2024 | Initiated by | HC Wainwright | Analyst S. Buck | Buy | $18.00 | N/A | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 11/26/2024 |
SAVA Cassava Sciences | $3.84
-3.5% | 11/26/2024 | Downgraded by | HC Wainwright | Analyst V. Bernardino | Buy -> Neutral | $116.00 | N/A | View details for HC Wainwright rating of Cassava Sciences (NASDAQ:SAVA) on 11/26/2024 |
TNYA Tenaya Therapeutics | $3.57
+8.5% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/25/2024 |
BLRX BioLineRx | $0.30
+3.4% | 11/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $21.00 -> $9.00 | N/A | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 11/25/2024 |
PTN Palatin Technologies | $1.14
+0.9% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 11/25/2024 |
RMTI Rockwell Medical | $2.29
+3.2% | 11/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $7.00 | N/A | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 11/25/2024 |
NRXP NRx Pharmaceuticals | $1.31
+1.6% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 -> $19.00 | N/A | View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 11/25/2024 |
LGVN Longeveron | $2.05
-0.5% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 11/25/2024 |
RAPT RAPT Therapeutics | $1.26
+2.4% | 11/25/2024 | Reiterated by | HC Wainwright | - | Neutral | | N/A | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 11/25/2024 |
AXSM Axsome Therapeutics | $98.22
-1.4% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $180.00 -> $180.00 | N/A | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 11/25/2024 |
LEXX Lexaria Bioscience | $2.08
-0.5% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Lexaria Bioscience (NASDAQ:LEXX) on 11/25/2024 |
ORKA Oruka Therapeutics | $21.73
+7.3% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $45.00 | N/A | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 11/25/2024 |
NGNE Neurogene | $25.43
-1.4% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 11/25/2024 |
RYTM Rhythm Pharmaceuticals | $62.04
-0.3% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $69.00 -> $69.00 | N/A | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 11/25/2024 |
CARM Carisma Therapeutics | $0.85
+1.6% | 11/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $5.00 | N/A | View details for HC Wainwright rating of Carisma Therapeutics (NASDAQ:CARM) on 11/25/2024 |
ABEO Abeona Therapeutics | $6.39
-0.3% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 11/25/2024 |
GANX Gain Therapeutics | $1.86
+6.9% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 11/25/2024 |
BBIO BridgeBio Pharma | $27.09
-1.5% | 11/25/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $43.00 -> $49.00 | N/A | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 11/25/2024 |
ASRT Assertio | $1.00
+2.3% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Assertio (NASDAQ:ASRT) on 11/25/2024 |
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad) I believe it’s going to power Elon Musk’s next AI revolution…
A revolution he believes will be worth more than $9 trillion.
That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. |
SRPT Sarepta Therapeutics | $133.34
-3.3% | 11/25/2024 | Initiated by | HC Wainwright | Analyst M. Kapoor | Sell | $80.00 | N/A | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/25/2024 |
IMUX Immunic | $1.24
+3.3% | 11/25/2024 | Initiated by | HC Wainwright | Analyst M. Caufield | Buy | $10.00 | N/A | View details for HC Wainwright rating of Immunic (NASDAQ:IMUX) on 11/25/2024 |
JAZZ Jazz Pharmaceuticals | $121.59
-0.9% | 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $200.00 -> $200.00 | N/A | View details for HC Wainwright rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 11/22/2024 |
DRTS Alpha Tau Medical | $2.80
| 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 11/22/2024 |
ZYME Zymeworks | $14.09
-2.3% | 11/22/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 11/22/2024 |
REPL Replimune Group | $14.08
+0.2% | 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 11/22/2024 |
KRRO Korro Bio | $52.06
-5.3% | 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $115.00 -> $115.00 | N/A | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 11/22/2024 |
RLYB Rallybio | $1.17
+6.4% | 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 11/22/2024 |
NVCR NovoCure | $20.04
+1.8% | 11/21/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 11/21/2024 |
ARBK Argo Blockchain | $1.12
+1.8% | 11/21/2024 | Reiterated by | HC Wainwright | - | Neutral | | N/A | View details for HC Wainwright rating of Argo Blockchain (NASDAQ:ARBK) on 11/21/2024 |
CAN Canaan | $2.12
+16.5% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Canaan (NASDAQ:CAN) on 11/21/2024 |
BMEA Biomea Fusion | $7.24
+3.1% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 11/21/2024 |
QSI Quantum-Si | $1.25
+9.6% | 11/21/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.00 -> $5.50 | N/A | View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 11/21/2024 |
LSTA Lisata Therapeutics | $2.76
-2.1% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 11/21/2024 |
PYXS Pyxis Oncology | $2.01
+9.8% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 11/21/2024 |
RGNX REGENXBIO | $9.92
-0.9% | 11/21/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $40.00 -> $36.00 | N/A | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 11/21/2024 |
MGX Metagenomi | $2.07
+2.5% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 11/21/2024 |
KURA Kura Oncology | $11.04
-1.2% | 11/21/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $32.00 -> $37.00 | N/A | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 11/21/2024 |
SAGE Sage Therapeutics | $5.47
-1.4% | 11/20/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 11/20/2024 |
ARGX argenx | $616.55
+0.3% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $617.00 -> $617.00 | N/A | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 11/20/2024 |
ARWR Arrowhead Pharmaceuticals | $26.03
-0.5% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 -> $60.00 | N/A | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 11/20/2024 |
PBYI Puma Biotechnology | $3.39
+5.0% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Puma Biotechnology (NASDAQ:PBYI) on 11/20/2024 |
VIR Vir Biotechnology | $7.96
+1.3% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $110.00 -> $110.00 | N/A | View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 11/20/2024 |
HALO Halozyme Therapeutics | $48.20
-0.6% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $68.00 -> $68.00 | N/A | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 11/20/2024 |
ELDN Eledon Pharmaceuticals | $4.66
+9.4% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 11/20/2024 |
GHRS GH Research | $8.93
-3.8% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 11/20/2024 |
FCUUF Fission Uranium | $0.61
+0.2% | 11/20/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.90 -> $2.00 | N/A | View details for HC Wainwright rating of Fission Uranium (OTCMKTS:FCUUF) on 11/20/2024 |
USAU U.S. Gold | $7.70
-6.3% | 11/20/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $11.00 -> $13.00 | N/A | View details for HC Wainwright rating of U.S. Gold (NASDAQ:USAU) on 11/20/2024 |
CLDX Celldex Therapeutics | $27.44
-1.6% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 11/20/2024 |
ZVRA Zevra Therapeutics | $9.33
-1.8% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 11/20/2024 |
IVVD Invivyd | $0.70
+2.9% | 11/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $10.00 | N/A | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 11/20/2024 |
CRDL Cardiol Therapeutics | $1.62
+2.5% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 11/20/2024 |
KYTX Kyverna Therapeutics | $5.77
+6.3% | 11/20/2024 | Target Lowered by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $7.00 -> $6.00 | N/A | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 11/20/2024 |
BEEM Beam Global | $3.87
+2.7% | 11/19/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $30.00 -> $8.00 | N/A | View details for HC Wainwright rating of Beam Global (NASDAQ:BEEM) on 11/19/2024 |
BRNS Barinthus Biotherapeutics | $0.99
+3.1% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 11/19/2024 |
ADVM Adverum Biotechnologies | $6.64
+2.9% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Adverum Biotechnologies (NASDAQ:ADVM) on 11/19/2024 |
BTBT Bit Digital | $4.61
+4.1% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 11/19/2024 |
BTDR Bitdeer Technologies Group | $14.27
+16.7% | 11/19/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $17.00 -> $18.00 | N/A | View details for HC Wainwright rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 11/19/2024 |
RANI Rani Therapeutics | $2.02
+1.5% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 11/19/2024 |
ANIX Anixa Biosciences | $3.30
-0.3% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 11/19/2024 |
HOWL Werewolf Therapeutics | $2.00
+1.5% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Werewolf Therapeutics (NASDAQ:HOWL) on 11/19/2024 |
EU enCore Energy | $3.78
+1.9% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of enCore Energy (NASDAQ:EU) on 11/19/2024 |
PTGX Protagonist Therapeutics | $43.80
-2.6% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 -> $50.00 | N/A | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 11/19/2024 |
ESPR Esperion Therapeutics | $2.80
+10.2% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 11/19/2024 |
NGNE Neurogene | $25.43
-1.4% | 11/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 11/19/2024 |
LRMR Larimar Therapeutics | $6.33
-4.7% | 11/18/2024 | Reiterated by | HC Wainwright | Analyst E. White | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Larimar Therapeutics (NASDAQ:LRMR) on 11/18/2024 |
ALNY Alnylam Pharmaceuticals | $253.07
-0.3% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $400.00 -> $400.00 | N/A | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/18/2024 |
INO Inovio Pharmaceuticals | $4.32
+3.1% | 11/18/2024 | Target Lowered by | HC Wainwright | - | Neutral -> Neutral | $12.00 -> $5.00 | N/A | View details for HC Wainwright rating of Inovio Pharmaceuticals (NASDAQ:INO) on 11/18/2024 |
ACET Adicet Bio | $1.13
+1.8% | 11/18/2024 | Reiterated by | HC Wainwright | Analyst E. White | Neutral | | N/A | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 11/18/2024 |
CYBN Cybin | $10.38
+1.3% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $190.00 -> $190.00 | N/A | View details for HC Wainwright rating of Cybin (NYSE:CYBN) on 11/18/2024 |
Media Is Mocking Elon, But Wait Until They See This Demo (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. |
ATAI Atai Life Sciences | $1.78
+2.9% | 11/18/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $10.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 11/18/2024 |
MVST Microvast | $0.76
-9.5% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Microvast (NASDAQ:MVST) on 11/18/2024 |
ZURA Zura Bio | $3.05
+1.7% | 11/18/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Zura Bio (NASDAQ:ZURA) on 11/18/2024 |
ANY Sphere 3D | $1.47
+6.5% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Sphere 3D (NASDAQ:ANY) on 11/18/2024 |
SNDX Syndax Pharmaceuticals | $16.72
+1.3% | 11/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $49.00 -> $51.00 | N/A | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 11/18/2024 |
ABUS Arbutus Biopharma | $3.46
-0.3% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Arbutus Biopharma (NASDAQ:ABUS) on 11/18/2024 |
STRO Sutro Biopharma | $2.65
-1.5% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 11/18/2024 |
BNTX BioNTech | $118.39
-1.9% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $150.00 -> $150.00 | N/A | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 11/18/2024 |
AKRO Akero Therapeutics | $32.10
-0.2% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 -> $50.00 | N/A | View details for HC Wainwright rating of Akero Therapeutics (NASDAQ:AKRO) on 11/18/2024 |
CYTK Cytokinetics | $51.86
-0.7% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | N/A | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 11/18/2024 |
APRE Aprea Therapeutics | $2.90
-2.7% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Aprea Therapeutics (NASDAQ:APRE) on 11/18/2024 |
FBIO Fortress Biotech | $2.13
+16.4% | 11/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $24.00 -> $26.00 | N/A | View details for HC Wainwright rating of Fortress Biotech (NASDAQ:FBIO) on 11/18/2024 |
SMMT Summit Therapeutics | $18.46
-2.5% | 11/18/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $44.00 -> $44.00 | N/A | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 11/18/2024 |
CADL Candel Therapeutics | $4.70
-5.1% | 11/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 11/18/2024 |
SRTS Sensus Healthcare | $8.51
-1.0% | 11/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $11.00 | N/A | View details for HC Wainwright rating of Sensus Healthcare (NASDAQ:SRTS) on 11/18/2024 |
BLFS BioLife Solutions | $27.47
+1.1% | 11/18/2024 | Target Lowered by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $29.00 -> $27.00 | N/A | View details for HC Wainwright rating of BioLife Solutions (NASDAQ:BLFS) on 11/18/2024 |
YMAB Y-mAbs Therapeutics | $11.92
+0.3% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 -> $22.00 | N/A | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 11/15/2024 |
ATNM Actinium Pharmaceuticals | $1.44
| 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 11/15/2024 |
AMTX Aemetis | $4.09
+3.3% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | N/A | View details for HC Wainwright rating of Aemetis (NASDAQ:AMTX) on 11/15/2024 |
WPRT Westport Fuel Systems | $4.75
+5.6% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 -> $22.00 | N/A | View details for HC Wainwright rating of Westport Fuel Systems (NASDAQ:WPRT) on 11/15/2024 |
PDSB PDS Biotechnology | $2.19
+1.9% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 11/15/2024 |
CRIS Curis | $4.39
-1.3% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 11/15/2024 |
CELC Celcuity | $12.80
-0.4% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 -> $27.00 | N/A | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 11/15/2024 |
SLN Silence Therapeutics | $7.92
+3.3% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 -> $75.00 | N/A | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 11/15/2024 |
KALA KALA BIO | $6.86
+3.2% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 11/15/2024 |
SGMT Sagimet Biosciences | $5.69
+2.7% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 -> $32.00 | N/A | View details for HC Wainwright rating of Sagimet Biosciences (NASDAQ:SGMT) on 11/15/2024 |
PPTA Perpetua Resources | $9.53
-2.4% | 11/15/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $13.25 -> $22.00 | N/A | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 11/15/2024 |
GOEV Canoo | $0.38
+5.5% | 11/15/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $4.00 -> $2.00 | N/A | View details for HC Wainwright rating of Canoo (NASDAQ:GOEV) on 11/15/2024 |
OBIO Orchestra BioMed | $5.63
-2.6% | 11/15/2024 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of Orchestra BioMed (NASDAQ:OBIO) on 11/15/2024 |
STTK Shattuck Labs | $1.10
+0.9% | 11/15/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Neutral | | N/A | View details for HC Wainwright rating of Shattuck Labs (NASDAQ:STTK) on 11/15/2024 |
INKT MiNK Therapeutics | $0.73
+1.4% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of MiNK Therapeutics (NASDAQ:INKT) on 11/15/2024 |
GOVX GeoVax Labs | $2.64
-2.6% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of GeoVax Labs (NASDAQ:GOVX) on 11/15/2024 |
DMAC DiaMedica Therapeutics | $5.66
+8.6% | 11/15/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 11/15/2024 |
CRBU Caribou Biosciences | $2.19
-0.5% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 11/15/2024 |
KOD Kodiak Sciences | $6.67
+1.8% | 11/15/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Neutral -> Neutral | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 11/15/2024 |
CRGX CARGO Therapeutics | $18.18
+2.9% | 11/15/2024 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $33.00 -> $33.00 | N/A | View details for HC Wainwright rating of CARGO Therapeutics (NASDAQ:CRGX) on 11/15/2024 |
AVBP ArriVent BioPharma | $29.96
+2.9% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $36.00 -> $36.00 | N/A | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 11/15/2024 |
IMAB I-Mab | $0.93
-2.0% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of I-Mab (NASDAQ:IMAB) on 11/15/2024 |
BPMC Blueprint Medicines | $96.38
+1.3% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $135.00 -> $135.00 | N/A | View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 11/15/2024 |
TCRX TScan Therapeutics | $4.77
| 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 11/15/2024 |
ANNX Annexon | $5.39
+0.9% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 11/15/2024 |
ACIU AC Immune | $3.40
+1.2% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 11/15/2024 |
ZNTL Zentalis Pharmaceuticals | $3.61
-0.6% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/15/2024 |
GALT Galectin Therapeutics | $2.89
+2.1% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 11/15/2024 |
OCUL Ocular Therapeutix | $9.89
-1.7% | 11/15/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $14.00 -> $15.00 | N/A | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 11/15/2024 |
SENS Senseonics | $0.31
| 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for HC Wainwright rating of Senseonics (NYSE:SENS) on 11/15/2024 |
DARE Daré Bioscience | $3.42
+3.6% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 11/15/2024 |
CABA Cabaletta Bio | $3.82
+26.9% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 11/15/2024 |
PSTX Poseida Therapeutics | $9.31
-0.2% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 11/15/2024 |
GNLX Genelux | $2.69
| 11/15/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $32.00 -> $30.00 | N/A | View details for HC Wainwright rating of Genelux (NASDAQ:GNLX) on 11/15/2024 |
Media Is Mocking Elon, But Wait Until They See This Demo (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. |
AFMD Affimed | $2.84
| 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Affimed (NASDAQ:AFMD) on 11/15/2024 |
LPTX Leap Therapeutics | $2.98
+2.1% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.50 -> $5.50 | N/A | View details for HC Wainwright rating of Leap Therapeutics (NASDAQ:LPTX) on 11/15/2024 |
ITOS iTeos Therapeutics | $8.55
+0.1% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $46.00 -> $46.00 | N/A | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 11/15/2024 |
PGEN Precigen | $0.93
+2.2% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 11/15/2024 |
SOL Emeren Group | $1.90
-2.1% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Emeren Group (NYSE:SOL) on 11/15/2024 |
RVYL Ryvyl | $1.73
-6.5% | 11/15/2024 | Reiterated by | HC Wainwright | - | Neutral | | N/A | View details for HC Wainwright rating of Ryvyl (NASDAQ:RVYL) on 11/15/2024 |
LMFA LM Funding America | $3.02
+1.3% | 11/15/2024 | Reiterated by | HC Wainwright | - | Neutral | | N/A | View details for HC Wainwright rating of LM Funding America (NASDAQ:LMFA) on 11/15/2024 |
FPAY FlexShopper | $1.98
+7.0% | 11/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of FlexShopper (NASDAQ:FPAY) on 11/15/2024 |
ADAP Adaptimmune Therapeutics | $0.72
-0.6% | 11/14/2024 | Target Lowered by | HC Wainwright | Analyst A. He | Buy -> Buy | $4.00 -> $3.50 | N/A | View details for HC Wainwright rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 11/14/2024 |
LQDA Liquidia | $11.55
-0.5% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 11/14/2024 |
KMDA Kamada | $5.89
+1.4% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Kamada (NASDAQ:KMDA) on 11/14/2024 |
SCPH scPharmaceuticals | $3.62
-3.2% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of scPharmaceuticals (NASDAQ:SCPH) on 11/14/2024 |
HUT Hut 8 | $28.02
-1.5% | 11/14/2024 | Target Raised by | HC Wainwright | Analyst M. Colonnese | Buy -> Buy | $26.00 -> $35.00 | N/A | View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 11/14/2024 |
XFOR X4 Pharmaceuticals | $0.39
| 11/14/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $5.00 -> $1.50 | N/A | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 11/14/2024 |
HIVE HIVE Digital Technologies | $4.08
+1.0% | 11/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $8.00 | N/A | View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 11/14/2024 |
CAPR Capricor Therapeutics | $19.01
-0.2% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $77.00 -> $77.00 | N/A | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 11/14/2024 |
SGMO Sangamo Therapeutics | $2.26
-1.7% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 11/14/2024 |
ATXS Astria Therapeutics | $10.39
-1.0% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 11/14/2024 |
BCDA BioCardia | $2.28
-3.0% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for HC Wainwright rating of BioCardia (NASDAQ:BCDA) on 11/14/2024 |
CKPT Checkpoint Therapeutics | $4.39
+2.6% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 11/14/2024 |
FDMT 4D Molecular Therapeutics | $7.84
-0.4% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $36.00 -> $36.00 | N/A | View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 11/14/2024 |
SLRN Acelyrin | $4.55
-0.4% | 11/14/2024 | Target Raised by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $6.00 -> $8.00 | N/A | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 11/14/2024 |
WYY WidePoint | $5.08
+2.4% | 11/14/2024 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of WidePoint (NYSEAMERICAN:WYY) on 11/14/2024 |
IDN Intellicheck | $2.39
-2.4% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 11/14/2024 |
SOUN SoundHound AI | $9.31
+18.1% | 11/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $8.00 | N/A | View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 11/14/2024 |
CLSD Clearside Biomedical | $1.05
-1.9% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | N/A | View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 11/14/2024 |
VYGR Voyager Therapeutics | $6.86
+18.7% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 11/14/2024 |
ASM Avino Silver & Gold Mines | $1.10
-0.9% | 11/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.50 -> $1.80 | N/A | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 11/14/2024 |
ASM Avino Silver & Gold Mines | $1.10
-0.9% | 11/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.50 -> $1.80 | N/A | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 11/14/2024 |
BHVN Biohaven | $46.01
-0.8% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 -> $59.00 | N/A | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 11/14/2024 |
VRDN Viridian Therapeutics | $21.55
-1.5% | 11/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $27.00 -> $34.00 | N/A | View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 11/14/2024 |
AURA Aura Biosciences | $9.31
+3.4% | 11/14/2024 | Reiterated by | HC Wainwright | Analyst E. White | Buy -> Buy | $22.00 -> $22.00 | N/A | View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 11/14/2024 |
ALT Altimmune | $8.57
-1.8% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 11/14/2024 |
ACRV Acrivon Therapeutics | $7.58
+0.8% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 -> $22.00 | N/A | View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 11/14/2024 |
CALC CalciMedica | $3.45
+0.3% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 11/14/2024 |
ONCY Oncolytics Biotech | $0.93
| 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 11/14/2024 |
LGO Largo | $2.10
| 11/14/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $4.40 -> $4.20 | N/A | View details for HC Wainwright rating of Largo (NYSE:LGO) on 11/14/2024 |
CLNN Clene | $4.18
+0.7% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 11/14/2024 |
OABI OmniAb | $3.91
+0.3% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of OmniAb (NASDAQ:OABI) on 11/14/2024 |
DYAI Dyadic International | $1.71
-8.6% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | N/A | View details for HC Wainwright rating of Dyadic International (NASDAQ:DYAI) on 11/14/2024 |
ALMS Alumis | $9.26
-4.7% | 11/14/2024 | Target Lowered by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $30.00 -> $26.00 | N/A | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 11/14/2024 |
DRRX DURECT | $0.88
-3.3% | 11/14/2024 | Reiterated by | HC Wainwright | - | Neutral | | N/A | View details for HC Wainwright rating of DURECT (NASDAQ:DRRX) on 11/14/2024 |
LXEO Lexeo Therapeutics | $8.23
+5.1% | 11/14/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $21.00 -> $23.00 | N/A | View details for HC Wainwright rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/14/2024 |
TIL Instil Bio | $26.91
-9.4% | 11/14/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $120.00 -> $110.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 11/14/2024 |
MRNS Marinus Pharmaceuticals | $0.32
-0.1% | 11/14/2024 | Reiterated by | HC Wainwright | Analyst D. Tsao | Neutral -> Neutral | $2.00 -> $2.00 | N/A | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 11/14/2024 |
MLTX MoonLake Immunotherapeutics | $54.43
+0.4% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 -> $100.00 | N/A | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/14/2024 |
FULC Fulcrum Therapeutics | $3.85
-2.5% | 11/14/2024 | Reiterated by | HC Wainwright | Analyst A. Fein | Neutral -> Neutral | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Fulcrum Therapeutics (NASDAQ:FULC) on 11/14/2024 |
TARA Protara Therapeutics | $3.01
-1.0% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 11/14/2024 |
ACXP Acurx Pharmaceuticals | $1.25
+8.7% | 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Acurx Pharmaceuticals (NASDAQ:ACXP) on 11/14/2024 |
BITF Bitfarms | $2.15
| 11/14/2024 | Reiterated by | HC Wainwright | Analyst M. Colonnese | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 11/14/2024 |
***TODAY ONLY*** Nvidia’s Next AI Play (Ad) Thanks to a specific AI Blueprint …
A small handful of companies have already soared as much as 562%, 3,247% and even 6,583%.
Now, with a massive recent $1 trillion pivot to data centers, six NEW stocks could be next in line to follow this pattern. Today only, the 2025 AI Blueprint has been revealed … |
YTRA Yatra Online | $1.40
| 11/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Yatra Online (NASDAQ:YTRA) on 11/14/2024 |
CRNX Crinetics Pharmaceuticals | $57.20
-0.8% | 11/13/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $69.00 -> $81.00 | N/A | View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 11/13/2024 |
TERN Terns Pharmaceuticals | $6.24
-1.6% | 11/13/2024 | Target Raised by | HC Wainwright | - | Neutral -> Neutral | $5.50 -> $7.50 | N/A | View details for HC Wainwright rating of Terns Pharmaceuticals (NASDAQ:TERN) on 11/13/2024 |
MYO Myomo | $5.62
+7.7% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.50 -> $7.50 | N/A | View details for HC Wainwright rating of Myomo (NYSEAMERICAN:MYO) on 11/13/2024 |
MIRM Mirum Pharmaceuticals | $46.22
-0.9% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $66.00 -> $66.00 | N/A | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 11/13/2024 |
IRON Disc Medicine | $63.45
-1.7% | 11/13/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $70.00 -> $118.00 | N/A | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 11/13/2024 |
ROIV Roivant Sciences | $12.71
+0.2% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 11/13/2024 |
OLMA Olema Pharmaceuticals | $10.12
| 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 11/13/2024 |
ATOS Atossa Therapeutics | $1.30
+1.6% | 11/13/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $6.00 -> $7.00 | N/A | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 11/13/2024 |
ABSI Absci | $3.05
+3.7% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 11/13/2024 |
BLTE Belite Bio | $63.26
-6.2% | 11/13/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $60.00 -> $100.00 | N/A | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 11/13/2024 |
KRRO Korro Bio | $52.06
-5.3% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $115.00 -> $115.00 | N/A | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 11/13/2024 |
NMRA Neumora Therapeutics | $9.94
+1.8% | 11/13/2024 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Neumora Therapeutics (NASDAQ:NMRA) on 11/13/2024 |
XENE Xenon Pharmaceuticals | $42.63
-1.2% | 11/13/2024 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $53.00 -> $53.00 | N/A | View details for HC Wainwright rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 11/13/2024 |
DYN Dyne Therapeutics | $30.61
-1.7% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 11/13/2024 |
ABOS Acumen Pharmaceuticals | $2.27
+0.4% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 11/13/2024 |
WVE Wave Life Sciences | $15.10
+0.7% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 -> $22.00 | N/A | View details for HC Wainwright rating of Wave Life Sciences (NASDAQ:WVE) on 11/13/2024 |
PRTA Prothena | $16.21
+2.1% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $84.00 -> $84.00 | N/A | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 11/13/2024 |
SVRA Savara | $3.36
-3.2% | 11/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $6.00 | N/A | View details for HC Wainwright rating of Savara (NASDAQ:SVRA) on 11/13/2024 |
QSI Quantum-Si | $1.25
+9.6% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 11/13/2024 |
ETON Eton Pharmaceuticals | $13.53
+6.2% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 11/13/2024 |
INAB IN8bio | $0.30
+2.9% | 11/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.50 -> $8.00 | N/A | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 11/13/2024 |
LFWD ReWalk Robotics | $2.07
-1.4% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:LFWD) on 11/13/2024 |
LEGN Legend Biotech | $42.07
-2.5% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $73.00 -> $73.00 | N/A | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 11/13/2024 |
IRD Opus Genetics | $1.11
+5.7% | 11/13/2024 | Initiated by | HC Wainwright | Analyst M. Caufield | Buy | $8.00 | N/A | View details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 11/13/2024 |
AVDL Avadel Pharmaceuticals | $11.06
-1.0% | 11/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $27.00 -> $25.00 | N/A | View details for HC Wainwright rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 11/13/2024 |
BOLT Bolt Biotherapeutics | $0.64
+3.2% | 11/13/2024 | Reiterated by | HC Wainwright | Analyst E. White | Neutral | | N/A | View details for HC Wainwright rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 11/13/2024 |
KURA Kura Oncology | $11.04
-1.2% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 -> $32.00 | N/A | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 11/13/2024 |
GEVO Gevo | $1.65
+3.4% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 11/13/2024 |
MAG MAG Silver | $15.37
+0.1% | 11/13/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $18.00 -> $20.00 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 11/13/2024 |
MARA MARA | $27.42
+1.9% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | N/A | View details for HC Wainwright rating of MARA (NASDAQ:MARA) on 11/13/2024 |
HUMA Humacyte | $4.52
+2.7% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 11/13/2024 |
ERAS Erasca | $2.86
-2.1% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | N/A | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 11/13/2024 |
LXRX Lexicon Pharmaceuticals | $0.80
| 11/13/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $6.00 -> $6.00 | N/A | View details for HC Wainwright rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 11/13/2024 |
TPST Tempest Therapeutics | $0.95
-1.0% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $47.00 -> $47.00 | N/A | View details for HC Wainwright rating of Tempest Therapeutics (NASDAQ:TPST) on 11/13/2024 |
OPTN OptiNose | $0.50
-6.6% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 11/13/2024 |
FBLG FibroBiologics | $2.62
+2.3% | 11/13/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of FibroBiologics (NASDAQ:FBLG) on 11/13/2024 |
FTCI FTC Solar | $0.32
-3.1% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $1.50 -> $1.50 | N/A | View details for HC Wainwright rating of FTC Solar (NASDAQ:FTCI) on 11/13/2024 |
PLUG Plug Power | $2.24
+5.2% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Plug Power (NASDAQ:PLUG) on 11/13/2024 |
KOPN Kopin | $1.18
+7.3% | 11/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Kopin (NASDAQ:KOPN) on 11/13/2024 |
PRME Prime Medicine | $3.29
-0.3% | 11/13/2024 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Prime Medicine (NYSE:PRME) on 11/13/2024 |
BCAB BioAtla | $1.68
+2.4% | 11/13/2024 | Downgraded by | HC Wainwright | Analyst A. He | Buy -> Neutral | | N/A | View details for HC Wainwright rating of BioAtla (NASDAQ:BCAB) on 11/13/2024 |
FF First Mining Gold | C$0.13
| 11/12/2024 | Target Lowered by | HC Wainwright | - | | C$0.80 -> C$0.35 | N/A | View details for HC Wainwright rating of First Mining Gold (TSE:FF) on 11/12/2024 |
SNDX Syndax Pharmaceuticals | $16.72
+1.3% | 11/12/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $47.00 -> $49.00 | N/A | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 11/12/2024 |
SRRK Scholar Rock | $39.90
+4.6% | 11/12/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $35.00 -> $40.00 | N/A | View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 11/12/2024 |
FEMY Femasys | $1.12
+7.7% | 11/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 11/12/2024 |
SWTX SpringWorks Therapeutics | $41.48
-0.6% | 11/12/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $76.00 -> $74.00 | N/A | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/12/2024 |
IOBT IO Biotech | $0.89
+4.7% | 11/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of IO Biotech (NASDAQ:IOBT) on 11/12/2024 |
REPL Replimune Group | $14.08
+0.2% | 11/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 11/12/2024 |
ARMP Armata Pharmaceuticals | $2.30
| 11/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 11/12/2024 |
AGEN Agenus | $3.42
-2.0% | 11/12/2024 | Target Lowered by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $8.00 -> $7.00 | N/A | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 11/12/2024 |
GAU Galiano Gold | $1.41
-2.1% | 11/12/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.20 -> $4.60 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 11/12/2024 |
CGON CG Oncology | $34.75
+1.9% | 11/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 -> $75.00 | N/A | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 11/12/2024 |
EMX EMX Royalty | $1.74
| 11/12/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $6.75 -> $7.00 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 11/12/2024 |
MLYS Mineralys Therapeutics | $12.77
-2.6% | 11/12/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 11/12/2024 |
NVAX Novavax | $8.72
+1.2% | 11/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 -> $19.00 | N/A | View details for HC Wainwright rating of Novavax (NASDAQ:NVAX) on 11/12/2024 |
UNCY Unicycive Therapeutics | $0.69
+1.6% | 11/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 11/12/2024 |
RAPT RAPT Therapeutics | $1.26
+2.4% | 11/12/2024 | Reiterated by | HC Wainwright | - | Neutral | | N/A | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 11/12/2024 |
LYEL Lyell Immunopharma | $0.95
+2.2% | 11/12/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $1.00 -> $1.00 | N/A | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 11/12/2024 |
NGNE Neurogene | $25.43
-1.4% | 11/12/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $49.00 -> $55.00 | N/A | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 11/12/2024 |
